Literature
Home药品天地专业药学实验技术色谱技术色谱论文

HPLC测定血浆中福辛普利的活性代谢物福辛普利拉浓度

来源:中国色谱网
摘要:NewPage1摘要:目的:建立人血浆中福辛普利拉HPLC测定法,为血药浓度监测和临床合理用药提供方法学基础。方法:血浆样品酸化后用乙醚-二氯甲烷混合溶媒提取,以双氯芬酸钠为内标,流动相为甲醇-10mmol·L-1磷酸氢二钾溶液(内含5mmol·L-1氯化四丁基铵)(68:32),磷酸调Ph至7。高中低浓度的3个质控样......

点击显示 收起

New Page 1

摘 要:目的:建立人血浆中福辛普利拉HPLC测定法,为血药浓度监测和临床合理用药提供方法学基础。方法:血浆样品酸化后用乙醚-二氯甲烷混合溶媒提取,以双氯芬酸钠为内标,流动相为甲醇-10mmol·L-1磷酸氢二钾溶液(内含5mmol·L-1氯化四丁基铵)(68:32),磷酸调Ph至7.6;流速为1.0Ml·min-1;检测波长210nm。结果:本法在10.5~1112.0ng·mL-1范围内线性良好,r=0.9988。高中低浓度的3个质控样品日内RSD<8.12%,日间RSD<8.10%,本法的相对误差<13.4%。血浆最低检测浓度为105ng·Ml-1结论:本法快速、准确、重现性好,适用于该药物临床血药浓度监测。


关键词:高效液相色谱法 福辛普利拉 药代动力学


分类号:R927 文献标识码:A

HPLC Determination of Fosinoprilat--Active Metabolite of Fosinopril in Human Plasma

LI Wen-yanShanghai Zhabei District Central Hospital,Shanghai 200070) 
JI Jia-zhuShanghai Zhabei District Central Hospital,Shanghai 200070) 
WU Xing-wenShanghai Zhabei District Central Hospital,Shanghai 200070) 
SHU WeiShanghai Zhabei District Central Hospital,Shanghai 200070) 
LI Wen -yanShanghai Zhabei District Central Hospital, Shanghai 200070) 
JI Jia- zhuShanghai Zhabei District Central Hospital, Shanghai 200070) 
WU Xing - wenShanghai Zhabei District Central Hospital, Shanghai 200070) 
SHU WeiShanghai Zhabei District Central Hospital, Shanghai 200070) 

AbstractObjective: To establish a HPLC assay method for the determination of fosinoprilat in human plasma. Method: A reversed phase ion - pair chromatographic method has been developed after the plasma samples having been ex tracted by ether- dichloromethane mixed solvent. Column: Hypersil ODS, 5 μm, 25 cm × 4.6 mm; Mobile phase:Methanol - 10 mmol· L-1 di - potassium hydrogen phosphate consisting of 5 mmol· L-1 tetra - butyl ammonium chloride (68:32), Ph was adjusted to 7.6 with phosphoric acid; Flow rate: 1.0 Ml·min-1; Detection wavelength: 210 nm. Results: Assay linearity was obtained in the range of 10.5 1112.0 ng·Ml ; intra- and inter- day precisions were lower than 8.12% and 8.10%, respectively; relative error of the method was lower than 13.4%; the lowest detectable concentration was 10.5 ng·Ml-1 Conclusion: The improved method is rapid, accurate and reproducible. It is suitable for therapeutic drug monitoring (TDM).


Keywords
HPLC, fosinoprilat, TDM

作者单位:李文艳(上海市闸北区中心医院上海 200070) 
     计家珠(上海市闸北区中心医院上海 200070) 
     吴兴文(上海市闸北区中心医院上海 200070) 
     舒薇(上海市闸北区中心医院上海 200070) 
     李文艳(上海市闸北区中心医院 上海 200070) 
     计家珠(上海市闸北区中心医院 上海 200070) 
     吴兴文(上海市闸北区中心医院 上海 200070) 
     舒薇(上海市闸北区中心医院 上海 200070) 

参考文献:

[1]Deforrest J M, Waldron T L, Harvey C M, et al. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and pre - clinical in vivo pharmacology. J Cardiovasc Pharmacol,1989, 14 (5): 730
[2]LI Wen -yan (李文彦),JI Jia- zhu (计家珠),GUO Ji - fen (郭继芬),et al. Pharmacokinetic tudy of oral fosinopril in healthy Chinese volunteers (中国健康志愿者口服福辛普利药代动力学研究).Acta Pharm Sin (药学学报),2000,35(8):601( inChinese)
[3]ChP(中国药典).2000.VolⅡ Appendix (附录) [3(本文于2000年2月1日收到)

收稿日期:2000年2月1日

出版日期:2001年3月31日

原载于《药物分析杂志》2001 Vol.21  No.2   P.100-103

http://search3721.sohu.com/go.phtml?coagent=sohu_go&fg=1&name=%CD%F2%B7%BD%CA%FD%BE%DD&url=http://www.wanfangdata.com.cn

作者: 李文艳 计家珠 吴兴文 舒薇 2007-5-18
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具